Xtl Biopharmaceuticals (XTLB) Consolidated Net Income (2009 - 2024)
Xtl Biopharmaceuticals (XTLB) recorded Consolidated Net Income of -$6.97 million in the year ended Dec 31, 2025, compared with -$1.03 million a year earlier.
Powered by 
Analysis
Xtl Biopharmaceuticals (XTLB) Consolidated Net Income (2009 - 2024) Analysis & Trends
Starting with the year ended Dec 31, 2009, Xtl Biopharmaceuticals' Consolidated Net Income history includes 17 years.
- The figure for the year ended Dec 31, 2025 is the lowest annual Consolidated Net Income in data going back to the year ended Dec 31, 2009.
- Per Business Quant data, XTLB's Consolidated Net Income was -$1.03 million in the year ended Dec 31, 2024, -$1.78 million in the year ended Dec 31, 2023, -$1.35 million in the year ended Dec 31, 2022 and $435,000 in the year ended Dec 31, 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | -237.00 Mn |
| 10 | Xtl Biopharmaceuticals | 2.13 Bn | 2.13 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -255,000.00 |
| Sep 30, 2024 | -553,000.00 |
| Jun 30, 2024 | -421,000.00 |
| Mar 31, 2024 | -175,000.00 |
| Dec 31, 2023 | -284,000.00 |
| Sep 30, 2023 | -215,000.00 |
| Jun 30, 2023 | -163,000.00 |
| Mar 31, 2023 | -251,000.00 |
| Dec 31, 2022 | -748,000.00 |
| Sep 30, 2022 | -821,000.00 |
| Jun 30, 2022 | -285,000.00 |
| Mar 31, 2022 | -249,000.00 |
| Dec 31, 2021 | -286,000.00 |
| Sep 30, 2021 | -210,000.00 |
| Jun 30, 2021 | -1.15 Mn |
| Mar 31, 2021 | 1.00 |
| Dec 31, 2020 | -2.00 |
| Sep 30, 2020 | -3.00 |
| Jun 30, 2020 | -1.11 Mn |
| Dec 31, 2019 | -1.35 Mn |
API Access
Xtl Biopharmaceuticals Consolidated Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=XTLB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "consolidated-net-income", "ticker": "XTLB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=XTLB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();